CAPLIN POINT LABORATORIES
Caplin Point Laboratories Share Price
Caplin Point Laboratories Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Caplin Point Laboratories Investment Rating
-
Master Rating:
-
Caplin Point Labs. has an operating revenue of Rs. 1,315.30 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 30% is great, ROE of 20% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 200DMA and around 6% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 93 which is a GREAT score indicating consistency in earnings, a RS Rating of 39 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 106 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
- Indicator
- Jun 2022
- Mar 2022
- Dec 2021
- Sep 2021
- Jun 2021
- Mar 2021
- Oper Rev Qtr Cr
- 116
- 112
- 128
- 160
- 128
- 123
- Operating Expenses Qtr Cr
- 70
- 74
- 75
- 89
- 71
- 80
- Operating Profit Qtr Cr
- 46
- 38
- 53
- 71
- 56
- 43
- Depreciation Qtr Cr
- 6
- 7
- 6
- 6
- 6
- 6
- Interest Qtr Cr
- 0
- 0
- 0
- 0
- 0
- 0
- Tax Qtr Cr
- 11
- 13
- 17
- 18
- 15
- 13
- Net Profit Qtr Cr
- 63
- 29
- 39
- 65
- 55
- 31
Caplin Point Laboratories Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 8
- Bearish Moving Average
- ___
- 8
- 20 Day
- 791.85
- 50 Day
- 768.21
- 100 Day
- 760.1
- 200 Day
- 767.04
- 20 Day
- 800.53
- 50 Day
- 750.32
- 100 Day
- 744.18
- 200 Day
- 766.71
Caplin Point Laboratories Resistance and Support
- First Resistance
- 804.64
- Second Resistance
- 812.97
- Third Resistance
- 818.44
- First Resistance
- 790.84
- Second Resistance
- 785.37
- Third Resistance
- 777.04
- RSI
- 48.33
- MFI
- 68.52
- MACD Single Line
- 17.74
- MACD
- 12.64
Caplin Point Laboratories Delivery and Volume
- Period
- NSE + BSE
Volume Avg - NSE + BSE
Delivery Volume Avg - NSE + BSE
Delivery Volume %
- Day
- 82,745
- 3,997,411
- 48.31
- Week
- 58,363
- 2,984,671
- 51.14
- 1 Month
- 142,166
- 5,009,919
- 35.24
- 6 Month
- 109,365
- 3,953,560
- 36.15
Caplin Point Laboratories Result Highlights
Caplin Point Laboratories Synopsis
NSE-Medical-Generic Drugs
Caplin Point Lab is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 482.68 Cr. and Equity Capital is Rs. 15.13 Cr. for the Year ended 31/03/2021. Caplin Point Laboratories Ltd. is a Public Limited Listed company incorporated on 16/04/1990 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24231TN1990PLC019053 and registration number is 019053.- Market Cap
- 5,908
- Sales
- 517
- Shares in Float
- 2.35
- No of funds
- 72
- Yield
- 0.51
- Book Value
- 6.35
- U/D Vol ratio
- 2.1
- LTDebt / Equity
- Alpha
- Beta
- 0.88
Caplin Point Laboratories
- Owner Name
- Jun-22
- Mar-22
- Dec-21
- Sep-21
- Promoters
- 68.88%
- 68.89%
- 68.91%
- Mutual Funds
- 1.06%
- 1.19%
- 1.16%
- Foreign Portfolio Investors
- 2.03%
- 2.07%
- 2.11%
- Financial Institutions/ Banks
- Individual Investors
- 20.77%
- 20.79%
- 20.79%
- Others
- 7.26%
- 7.06%
- 7.03%
Caplin Point Laboratories Management
- Name
- Designation
- Mr. C C Paarthipan
- Chairman
- Dr. Sridhar Ganesan
- Managing Director
- Mr. V Thirumalai
- Independent Director
- Mr. R Viswanathan
- Independent Director
- Dr. K C John
- Independent Director
- Mr. D Sathyanarayanan
- Independent Director
- Dr. C K Gariyali
- Independent Director
- Mr. D P Mishra
- Director
Caplin Point Laboratories Forecast
Price Estimates
Caplin Point Laboratories Corporate Action
- Date
- Purpose
- Remarks
- 2022-08-05
- Quarterly Results & Final Dividend
- 2022-05-12
- Audited Results & Interim Dividend
- 2022-02-03
- Quarterly Results
- 2021-11-02
- Quarterly Results
- 2021-08-05
- Quarterly Results & Final Dividend
- Date
- Purpose
- Remarks
- 2022-05-24
- INTERIM
- Rs.2.00 per share(100%)Interim Dividend
- 2021-05-19
- INTERIM
- Rs.1.50 per share(75%)Interim Dividend
Caplin Point Laboratories FAQs
What is Share Price of Caplin Point Laboratories ?
Caplin Point Laboratories share price is ₹779 As on 20 August, 2022 | 06:59
What is the Market Cap of Caplin Point Laboratories ?
The Market Cap of Caplin Point Laboratories is ₹5907.5 Cr As on 20 August, 2022 | 06:59
What is the P/E ratio of Caplin Point Laboratories ?
The P/E ratio of Caplin Point Laboratories is 18.8 As on 20 August, 2022 | 06:59
What is the PB ratio of Caplin Point Laboratories ?
The PB ratio of Caplin Point Laboratories is 3.9 As on 20 August, 2022 | 06:59